Ignite Creation Date:
2024-07-17 @ 11:00 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495125
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Defactinib Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Sponsor:
Emory University
Organization:
Emory University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Lung Adenocarcinoma |
| Refractory Lung Adenocarcinoma |
| Stage III Lung Cancer AJCC v8 |
| Stage IV Lung Cancer AJCC v8 |
Keywords: